# Safety Study of PLX108-01 in Patients With Solid Tumors

> **NCT01004861** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 132 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** PLX3397

## Key facts

- **NCT ID:** NCT01004861
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-01
- **Primary completion:** 2018-01-31
- **Final completion:** 2018-10-25
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2022-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004861, "Safety Study of PLX108-01 in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01004861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*